We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
AusPAR: Vaxneuvance
Australian Public Assessment Report
Device/Product Name
Vaxneuvance
Active ingredients
Pneumococcal 15-valent conjugate vaccine (CRM197 protein), adsorbed
AusPAR Date
Published
Submission Number
PM-2022-00382-1-2
Submission Type
Extension of indication
Decision
Approved